Can overall results of clinical trials be applied to all patients? - PubMed (original) (raw)
Comparative Study
. 1995 Jun 24;345(8965):1616-9.
doi: 10.1016/s0140-6736(95)90120-5.
Affiliations
- PMID: 7783541
- DOI: 10.1016/s0140-6736(95)90120-5
Comparative Study
Can overall results of clinical trials be applied to all patients?
P M Rothwell. Lancet. 1995.
Abstract
It is generally assumed that the overall results of a clinical trial are generalisable to all patients in the trial and all similar future patients; in other words, that the relative treatment effect in individual patients is similar to the overall trial result. Although this assumption underpins the application of trial results to clinical practice, it has rarely been tested. By independently derived prognostic models, the results of the European Carotid Surgery Trial and the UK-TIA Aspirin Trial were reanalysed to find out whether relative treatment effect varied with absolute baseline risk of stroke. There was significant heterogeneity of relative treatment effect in both trials, resulting in substantial variation in absolute treatment effect with predicted baseline risk. Although, on average, the application of overall trial results to all patients will do more good than harm, a knowledge of the association between relative treatment effect and absolute baseline risk will increase the cost-effectiveness of healthcare interventions by identifying those patients in whom treatment is ineffective and those patients who are most likely to benefit.
Comment in
- Can overall results of clinical trials be applied to all patients?
Fayers P. Fayers P. Lancet. 1995 Aug 12;346(8972):445-6. Lancet. 1995. PMID: 7623594 No abstract available. - Can overall results of clinical trials be applied to all patients?
Ranaboldo CJ, Chant AD. Ranaboldo CJ, et al. Lancet. 1995 Aug 12;346(8972):446. Lancet. 1995. PMID: 7677909 No abstract available.
Similar articles
- Variation in the use of angiography and carotid endarterectomy by neurologists in the UK-TIA aspirin trial.
[No authors listed] [No authors listed] Br Med J (Clin Res Ed). 1983 Feb 12;286(6364):514-7. doi: 10.1136/bmj.286.6364.514. Br Med J (Clin Res Ed). 1983. PMID: 6402129 Free PMC article. Clinical Trial. - Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group.
Rothwell PM, Warlow CP. Rothwell PM, et al. Lancet. 1999 Jun 19;353(9170):2105-10. doi: 10.1016/s0140-6736(98)11415-0. Lancet. 1999. PMID: 10382694 Clinical Trial. - Carotid endarterectomy. Management of transient ischemic attack and asymptomatic carotid stenosis.
Barry R, Grobler SP, Nel CJ. Barry R, et al. Surg Annu. 1995;27:185-98. Surg Annu. 1995. PMID: 7597550 Review. No abstract available. - Endarterectomy for symptomatic carotid stenosis. Review of the European and North American Symptomatic Carotid Surgery Trials.
Gasecki AP, Hachinski VC, Mendel T, Barnett HT. Gasecki AP, et al. Nebr Med J. 1992 Jun;77(6):121-3. Nebr Med J. 1992. PMID: 1620265 Review.
Cited by
- Predictive approaches to heterogeneous treatment effects: a scoping review.
Rekkas A, Paulus JK, Raman G, Wong JB, Steyerberg EW, Rijnbeek PR, Kent DM, van Klaveren D. Rekkas A, et al. BMC Med Res Methodol. 2020 Oct 23;20(1):264. doi: 10.1186/s12874-020-01145-1. BMC Med Res Methodol. 2020. PMID: 33096986 Free PMC article. - Common errors and controversies in pharmacoeconomic analyses.
Soto J. Soto J. Pharmacoeconomics. 1998 Dec;14(6):711-4. doi: 10.2165/00019053-199814060-00012. Pharmacoeconomics. 1998. PMID: 10346422 No abstract available. - Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading.
Smeeth L, Haines A, Ebrahim S. Smeeth L, et al. BMJ. 1999 Jun 5;318(7197):1548-51. doi: 10.1136/bmj.318.7197.1548. BMJ. 1999. PMID: 10356018 Free PMC article. Review. No abstract available. - Impact of the PATH Statement on Analysis and Reporting of Heterogeneity of Treatment Effect in Clinical Trials: A Scoping Review.
Selby JV, Maas CCHM, Fireman BH, Kent DM. Selby JV, et al. medRxiv [Preprint]. 2024 May 6:2024.05.06.24306774. doi: 10.1101/2024.05.06.24306774. medRxiv. 2024. PMID: 38766150 Free PMC article. Preprint. - The potential benefit of statin prescription based on prediction of treatment responsiveness in older individuals: an application to the PROSPER randomized controlled trial.
Nguyen TL, Trompet S, Brodersen JB, Hoogland J, Debray TPA, Sattar N, Jukema JW, Westendorp RGJ. Nguyen TL, et al. Eur J Prev Cardiol. 2024 Jun 3;31(8):945-953. doi: 10.1093/eurjpc/zwad383. Eur J Prev Cardiol. 2024. PMID: 38085032 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical